| |
|
| |
|
| |
|
|
Aortx
AorTx, Inc. (previously CardiacMD) is developing device solutions that rapidly convert aortic valve replacement to a minimally invasive,
percutaneous, approach. AorTx is developing devices that cover the entire procedural solution for percutaneous heart valve therapy--
from the implant itself to delivery and deployment of the valve.
|
| |
|
| |
|
|
Asthmatx
Asthmatx is developing an interventional medical device for the bronchoscopic treatment of patients with moderate to severe asthma.
http://www.asthmatx.com/
|
| |
|
| |
|
| |
|
Atrionix, Inc.
|
Atrionix
Developing a minimally invasive cather based treatment for atrial fibrillation.
Acquired by Johnson & Johnson January 16, 2001.
|
| |
|
| |
|
| |
|
|
Bacchus Vascular, Inc.
Therapeutic devices to treat vascular obstructions.
3110 Coronado Drive
Santa Clara, CA 95054
Tel: 408.980.8300
http://bacchusvascular.com
|
| |
|
| |
|
| |
|
Bio Interventional Inc. |
Bio Interventional Inc.
Developing products to facilitate hemostasis at the fermoral ateriotomy site created during diagnostic angiogram procedures.
5990 Stoneridge Dr, Ste 112
Pleasanton, CA 94588
Tel: 925.737.1860
|
| |
|
| |
|
| |
|
|
Calcitec, Inc.
Calcitec is developing synthetic bone substitutes optimized for orthopedic and neurosurgical applications.
http://www.calcitecinc.com
|
| |
|
| |
|
|
Converge Medical, Inc.
Develops novel medical devices designed to enable surgeons to perform faster, less invasive surgery
utilizing suchureless vascular anastomoses during a variety of surgical procedures, including coronary artery bypass grafting (CABG).
Status: Company out of business.
|
| |
|
| |
|
| |
|
|
Corazon, Inc.
Developing proprietary technologies designed to help physicians manage calcific cardiovascular and valvular disease
during interventional and surgical procedures.
Status: Company out of business.
|
| |
|
| |
|
| |
|
|
CryoVascular Systems, Inc.
Therapeutic devices to treat coronary artery disease.
Acquired by Boston Scientific March 2005.
160 Knowles Drive
Los Gatos, CA 95032
Tel: 408.376.3675
http://www.cryoinc.com/
|
| |
|
| |
|
| |
|
|
Cytograft Tissue Engineering
Cytograft has an innovative technology called sheet-based tissue engineering .
The goal is a tissue-engineered blood vessel as an alternative for bypass candidates
lacking the healthy native vessels required for traditional vascular reconstruction.
http://www.cytograft.com/
|
| |
|
| |
|
| |
|
|
EndoTex Interventional Systems, Inc.
Focused on developing a less invasive solution to treating carotid artery disease.
10231 Bubb Road
Cupertino, CA 95014
Tel: 888.336.3683
http://www.endotex.com
|
| |
|
| |
|
| |
|
|
Enteric Medical Technologies, Inc.
Primary focus is the treatment of gastroesophageal reflux disease (GERD), which occurs in 40 million Americans.
Acquired by Boston Scientific in June 2002.
Tel: 650.565.9814
http://www.bostonscientific.com
|
| |
|
| |
|
| |
|
Ensure Medical
|
Ensure Medical (formerly COR Medical)
Ensure Medical has developed a biodegradable, plug-based, femoral closure device.
Acquired by Cordis/JNJ June 2006.
|
| |
|
| |
|
| |
|
|
Intact Medical, Inc.
Developing innovative minimally invasive systems for the volumetric excision of tissue for diagnostic and therapeutic applications
in select cancer markets. Initial products will be targeted at breast biopsy.
One Apple Hill, Suite 316
Natick, MA 01760
Tel: 888.430.4490
http://www.intactmedical.com
|
| |
|
| |
|
| |
|
Integrated Vascular Systems
|
Integrated Vascular Systems
Developing next generation proprietary vascular closure devices for use in endovascular diagnostic and therapeutic applications.
Acquired by Abbott Laboratories in September 2003.
|
| |
|
| |
|
| |
|
|
|
| |
|
| |
|
|
|
|
LuMend, Inc.
LuMend's products enable physicians to safely, predictably, and cost-effectively cross chronic total occlusions in blood vessels,
and allow for subsequent treatment using catheter-based, minimally invasive procedures.
Acquired by Cordis/JNJ February 2006.
400 Chesapeake Drive
Redwood City, CA 94063
Tel: 650.364.1400
http://www.lumend.com
|
| |
|
| |
|
| |
|
|
Nellix, Inc.
Nellix develops disruptive technology for the percutaneous treatment of Abdominal Aortic Aneurysms and Thoracic Aortic Aneurysms.
http://www.nellix.com/
|
| |
|
| |
|
| |
|
|
Oratec Interventions, Inc.
Manufactures specialized instruments for use in minimally invasive arthroscopic and spinal treatment modalities.
Acquired by Smith & Nephew in February 2002.
http://www.oratec.com
|
| |
|
| |
|
| |
|
|
Paracor Surgical, Inc.
A company creating a novel device platform that will transform the treatment and prevention of Congestive Heart Failure (CHF).
610 North Mary Avenue
Sunnyvale, CA 94085
Tel: 408.701.3250
http://www.paracorsurgical.com
|
| |
|
| |
|
| |
|
|
Point Biomedical, Inc.
Developer of a microsphere that freely circulates when injected into the bloodstream to deliver a variety of diagnostic or therapeutic agents.
887A Industrial Road
San Carlos, CA 94070
Tel: 650.596.1400
http://www.pointbio.com
|
| |
|
| |
|
| |
|
Salient Interventions Inc. |
Salient Interventions Inc.
Developing products focused on early treatment of neurologic diseases and reversal of neurologic deficits.
Status: Company out of business.
|
| |
|
| |
|
| |
|
Sapphire Medical |
Sapphire Medical
Sapphire Medical provides new devices for shoulder repair.
|
| |
|
| |
|
| |
|
Setagon, Inc. |
Setagon, Inc
Setagon Inc. is a company developing a next-generation drug delivery system for the emerging market of coated stents.
Their technology seeks to improve on the current polymer used for stent drug delivery by using a proprietary, metallic nanoporous coating.
|
| |
|
| |
|
| |
|
Sinus Rhythm Technologies |
Sinus Rhythm Technologies
Sinus Rhythm Technologies Inc treat causes of atrial fibrillation
with an implanted apparatus that creates scar tissue and blocks electrical current.
|
| |
|
| |
|
| |
|
|
|
| |
|
| |
|
| |
|
|
TheraCardia
Develop devices to increase survival rate of patients suffering from cardiac arrest, myocardial infarct and other forms of heart disease.
Technology unsuccessful. Company dissolved January 2003.
|
| |
|
| |
|
| |
|
|
TriVascular, Inc.
A medical device company developing highly advanced, innovative products for the treatment of cardiovascular disease.
Acquired by Boston Scientific February 2005.
3660 North Laughlin Road
Santa Rosa, CA 95403
Tel: 707.541.3900
http://www.trivascular.com
|
| |
|
| |
|
